Get the Stockscreener App
22.96
1.03%
-0.2382
Pre-market:
23.70
0.7382
+3.21%
Precipio Inc stock is traded at $22.96, with a volume of 26,364.
It is down -1.03% in the last 24 hours and down -3.52% over the past month.
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
See More
Previous Close:
$23.20
Open:
$23.17
24h Volume:
26,364
Relative Volume:
0.76
Market Cap:
$41.04M
Revenue:
$24.05M
Net Income/Loss:
$-363.00K
P/E Ratio:
-77.86
EPS:
-0.2949
Net Cash Flow:
$359.00K
1W Performance:
+2.69%
1M Performance:
-3.52%
6M Performance:
-3.87%
1Y Performance:
+105.57%
1-Day Range:
$22.42
$23.75
1-Week Range:
$22.14
$23.99
52-Week Range:
$10.60
$33.63
Precipio Inc Stock (PRPO) Company Profile
Name
Precipio Inc
Sector
Industry
Phone
203 787 7888
Address
4 SCIENCE PARK, NEW HAVEN, CT
Compare PRPO vs TMO, DHR, IDXX, NTRA, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRPO
Precipio Inc
|
22.96 | 41.04M | 24.05M | -363.00K | 359.00K | -0.2949 |
TMO
Thermo Fisher Scientific Inc
|
492.20 | 182.91B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
188.87 | 133.68B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
549.16 | 43.32B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
259.97 | 37.23B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
131.63 | 37.18B | 7.23B | 1.41B | 1.09B | 4.979 |
Precipio Inc Stock (PRPO) Latest News
Precipio Inc (PRPO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Precipio Inc (PRPO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Precipio Inc (PRPO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Precipio Inc (PRPO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Precipio Inc (PRPO) Institutional Confidence - TradingKey
Precipio Inc (PRPO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Precipio Inc (PRPO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Precipio Inc (PRPO) Valuation: PE, PB & Fair Value Analysis - TradingKey
Precipio Inc (PRPO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
PRPO: Rapid, profitable growth driven by innovative four-hour cancer diagnostics and scalable operations - TradingView
PRPO: Rapid, profitable growth driven by innovative diagnostics and strong customer retention - TradingView
Precipio (PRPO) AGM 2026 Summary - Quartr
Precipio Shareholders Back Board Nominees and Auditor - TipRanks
[8-K] Precipio, Inc. Reports Material Event - Stock Titan
Precipio to Present at the Planet MicroCap Las Vegas - The National Law Review
Precipio Inc Annual Shareholders Meeting Transcript - GuruFocus
Precipio Inc. (PRPO) Q2 2025 Earnings: Positive EPS Achieved Amid Stock DeclineEBITDA Analysis - newsline.com
Precipio urges shareholders to vote ahead of Saturday meeting - Investing.com
Precipio urges shareholders to vote ahead of Saturday meeting By Investing.com - Investing.com Australia
Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting - The Manila Times
Lack of quorum may force costly delay of Precipio shareholder meeting - Stock Titan
Cancer diagnostics firm Precipio heads to Vegas for Planet MicroCap 2026 - Stock Titan
Avoiding Lag: Real-Time Signals in (PRPO) Movement - Stock Traders Daily
Precipio Inc. (PRPO) Edges Higher Amid Consolidation Near ResistanceShort Setup Alerts - newsline.com
Precipio Inc. (PRPO) Edges Higher as Stock Nears ResistanceSell Signal Alerts - newsline.com
Precipio (PRPO) Q1 2026 Earnings Call Transcript - AOL.com
Precipio Q2 2025 Earnings: Positive EPS Marks a Milestone Despite Market ReactionMargin Compression Risk - newsline.com
Precipio (PRPO) Q4 2025 Earnings Transcript - AOL.com
PRPO Q2 2025 Earnings: Profitable Quarter Achieved Despite Revenue UncertaintyRevenue Breakdown Analysis - newsline.com
Discipline and Rules-Based Execution in PRPO Response - Stock Traders Daily
PRPO Q2 2025 Earnings: Positive EPS Marks a Turning Point for Diagnostic PlatformEarnings Growth Forecast - The Legal Advocate
Precipio director Richard Sandberg sells $22,517 in common stock By Investing.com - Investing.com Nigeria
Precipio director Richard Sandberg sells $22,517 in common stock - Investing.com
Precipio (PRPO) director-linked entity reports 900-share open-market sale - Stock Titan
Number of shareholders of Precipio, Inc. – GETTEX:TGK - TradingView
Precipio Q2 2025 Earnings: Company Reports Positive EPS of $0.05; Stock Declines 3.09%Growth Acceleration Report - thelegaladvocate.com
Precipio Inc. (PRPO) Q2 2025 Earnings: Unexpected Profitability Amid Revenue ChallengesEPS Growth Report - newsline.com
Precipio Stock Slides Before Holiday — Why Tuesday’s Open Matters - Bez Kabli
Precipio Stock Slips Post Q1 Earnings Despite Revenue Growth - TradingView
Precipio (PRPO) director Sandberg reports 3,134-share net stock sale in Form 4 - Stock Titan
Precipio Inc (PRPO) Q1 2026 Earnings Call Highlights: Revenue Growth Amidst Margin Challenges By GuruFocus - Investing.com Canada
Precipio Inc (PRPO) Q1 2026 Earnings Call Highlights: Revenue Gr - GuruFocus
Earnings call transcript: Precipio Inc Q1 2026 sees revenue growth amid margin pressures - Investing.com Nigeria
Insider sales at PRPO (NASDAQ: PRPO) list 500, 101 and 1,399-share trades - Stock Titan
Q1 2026 Precipio Inc Earnings Call Transcript - GuruFocus
Precipio Inc Stock (PRPO) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):